Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL27623894 | 0.97 | USP2 (0.35) | USP2TSHRCA1CA2ALDH1A1 | |
| Fluoride SCHEMBL779013 | 0.97 | USP2 (0.35) | USP2TSHRCA1CA2ALDH1A1 | |
| SCHEMBL778396 | 0.83 | TDP1 (0.31) | TSHRALDH1A1 | |
| Fluoride SCHEMBL776325 | 0.80 | — | — | |
| SCHEMBL28423375 | 0.78 | — | — | |
| SCHEMBL24067562 | 0.73 | — | — | |
| SCHEMBL28581755 | 0.73 | USP2 (0.35) | USP2TSHRCA1CA2 | |
| SCHEMBL28709145 | 0.73 | USP2 (0.35) | USP2TSHRCA1CA2ALDH1A1 | |
| SCHEMBL779321 | 0.73 | USP2 (0.35) | USP2TSHRCA1CA2 | |
| SCHEMBL18632049 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11860537-B2 | Positive type photosensitive siloxane composition and cured film formed by using the same | MERCK PATENT GMBH (DE) | 2024-01-02 | — | — | US | disclosed |
| US-20210116811-A1 | POSITIVE TYPE PHOTOSENSITIVE SILOXANE COMPOSITION AND CURED FILM FORMED BY USING THE SAME | MERCK PATENT GMBH (DE) | 2021-04-22 | — | — | US | disclosed |
| US-20150150981-A1 | ORGANIC-INORGANIC HYBRID SOLID HAVING A MODIFIED OUTER SURFACE | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE-CNRS (FR) | 2015-06-04 | — | — | US | disclosed |
| US-8460821-B2 | Non-aqueous electrolyte secondary battery, non-aqueous electrolyte, and method for fabricating non-aqueous electrolyte secondary battery | GS YUASA INTERNATIONAL LTD. (JP) | 2013-06-11 | — | — | US | disclosed |
| US-20110318655-A1 | NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY, NON-AQUEOUS ELECTROLYTE, AND METHOD FOR FABRICATNG NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY | GS YUASA INTERNATIONAL LTD. (JP) | 2011-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150150981-A1 | ORGANIC-INORGANIC HYBRID SOLID HAVING A MODIFIED OUTER SURFACE | SLCO4C1, SLCO2A1, SLCO1A2 | USP2 2625/4885TSHR 1448/4885CA1 1157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.